The scientist’s investigation covers issues in Mycobacterium tuberculosis, Biochemistry, Microbiology, Tuberculosis and Mutant. His study in Mycobacterium tuberculosis is interdisciplinary in nature, drawing from both Periplasmic space, Mode of action and Bacterial outer membrane. His Biochemistry research integrates issues from Mycobacterium, Mycolic acid and Mycobacterium smegmatis.
The concepts of his Microbiology study are interwoven with issues in Virulence factor, Virulence, Biofilm, Lipoarabinomannan and Immune system. His Tuberculosis research includes elements of Biogenesis, High-content screening and Virology. His research investigates the connection between Mutant and topics such as Origin of replication that intersect with problems in Peptidoglycan, Mutase and Insertional mutagenesis.
His scientific interests lie mostly in Mycobacterium tuberculosis, Microbiology, Biochemistry, Mycobacterium and Tuberculosis. His study looks at the relationship between Mycobacterium tuberculosis and fields such as Gene, as well as how they intersect with chemical problems. Mary Jackson combines subjects such as Mycobacterium bovis, Virology, Bacteria, Mycobacterium abscessus and Virulence with his study of Microbiology.
His Biochemistry research includes themes of Lipoarabinomannan and Mycobacterium smegmatis. His research in Lipoarabinomannan intersects with topics in DC-SIGN and Mannan. His studies deal with areas such as Phosphatidylinositol and Mannosyltransferase as well as Mycobacterium smegmatis.
Mary Jackson mostly deals with Mycobacterium tuberculosis, Biochemistry, Microbiology, Mycobacterium abscessus and Mycobacterium. His study on Mycobacterium tuberculosis is covered under Tuberculosis. Mary Jackson interconnects Mycobacterium smegmatis and Lipoarabinomannan in the investigation of issues within Biochemistry.
His Lipoarabinomannan research incorporates elements of Cell envelope and Mannan. His work on Pathogen as part of his general Microbiology study is frequently connected to Mycelium, thereby bridging the divide between different branches of science. His biological study spans a wide range of topics, including In vitro, Drug development, Mutant, Gene and Phenotypic screening.
Mary Jackson mainly investigates Mycobacterium tuberculosis, Biochemistry, Mycobacterium, Nontuberculous mycobacteria and Minimum inhibitory concentration. His Mycobacterium tuberculosis study deals with the bigger picture of Tuberculosis. His Mycobacterium research is multidisciplinary, relying on both Oral administration, Transporter, Spleen and Lung, Lung Disorder.
His Nontuberculous mycobacteria study integrates concerns from other disciplines, such as Mycobacterium Infections, Translational science, Drug resistance and Intensive care medicine. His Minimum inhibitory concentration study incorporates themes from Serine and Mycobacterium smegmatis. His studies in Mycobacterium abscessus integrate themes in fields like In vivo and Microbiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
DC-SIGN Is the Major Mycobacterium tuberculosis Receptor on Human Dendritic Cells
Ludovic Tailleux;Olivier Schwartz;Jean-Louis Herrmann;Elisabeth Pivert.
Journal of Experimental Medicine (2003)
Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis
Vladimir Pelicic;Mary Jackson;Jean Marc Reyrat;William R. Jacobs.
Proceedings of the National Academy of Sciences of the United States of America (1997)
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis.
Kevin Pethe;Pablo Bifani;Jichan Jang;Sunhee Kang.
Nature Medicine (2013)
Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane
Anna E Grzegorzewicz;Ha Pham;Vijay A K B Gundi;Michael S Scherman.
Nature Chemical Biology (2012)
Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope.
Mary Jackson;Catherine Raynaud;Marie‐Antoinette Lanéelle;Christophe Guilhot.
Molecular Microbiology (1999)
The Cell Surface Receptor DC-SIGN Discriminates betweenMycobacterium Species through Selective Recognition of the Mannose Caps on Lipoarabinomannan
Norihiro Maeda;Jérôme Nigou;Jean-Louis Herrmann;Mary Jackson.
Journal of Biological Chemistry (2003)
High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors.
Thierry Christophe;Mary Jackson;Hee Kyoung Jeon;Denis Fenistein.
PLOS Pathogens (2009)
Cell Wall Core Galactofuran Synthesis Is Essential for Growth of Mycobacteria
Fei Pan;Mary Jackson;Yufang Ma;Michael McNeil.
Journal of Bacteriology (2001)
Chapter 2: Biogenesis of the cell wall and other glycoconjugates of Mycobacterium tuberculosis.
Devinder Kaur;Marcelo E. Guerin;Henrieta Škovierová;Patrick J. Brennan.
Advances in Applied Microbiology (2009)
Phosphatidylinositol Is an Essential Phospholipid of Mycobacteria
Mary Jackson;Dean C. Crick;Patrick J. Brennan.
Journal of Biological Chemistry (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: